Cleerly Secures $192M for Heart Attack-Predicting AI Technology
The information provided in the search results does not match the query about Cleerly collecting $106M for its coronary artery scanning AI. Instead, the relevant information from the search results indicates that Cleerly collected $192M in funding for its heart attack-predicting AI technology2.
Funding Amount:
Cleerly secured $192M in funding to expand its team and commercial reach, as well as support ongoing clinical trials2.
Technology Overview:
Cleerly's AI analyzes non-invasive CT angiography scans to characterize and measure plaque buildup in the arteries, predicting the risk of heart attacks23.
Clinical Trials:
The company is conducting extensive clinical trials, including the TRANSFORM trial, which aims to enroll over 7,500 patients across more than 100 sites over a five-year period1.
Accuracy:
Cleerly's AI has demonstrated high accuracy in detecting heart disease, with 94% sensitivity and up to 82% specificity compared to invasive angiography3.
Medicare Coverage:
Medicare Administrative Contractors have approved coverage for Cleerly's AI heart scans for seniors with stable and acute symptoms of coronary artery disease, effective November 24, 20244.
Sources:
2. https://www.fiercebiotech.com/medtech/cleerly-quadruples-previous-funding-192m-heart-attack-predicting-ai
3. https://www.fiercebiotech.com/medtech/cleerlys-ai-comparable-gold-standard-invasive-angiography-detecting-heart-disease-study
4. https://www.businesswire.com/news/home/20241014694634/en/Medicare-Administrative-Contractors-Approve-Coverage-of-Cleerly-Heart-Scans-to-Medicare-Recipients